Skip to content
logo-orbit-white
Main Menu
  • Training Courses
    • RRI Training
    • Trusted Research
    • Design of Ethical AI Systems
    • Stakeholder Engagement
    • Data Governance
    • Ethical Hackathons
    • Responsible Quantum Technologies
    • Environmentally Sustainable Research
  • Resources & Tools
    • AREA 4P Framework
    • The Keys of RRI
    • About RRI Maturity
    • Self Assessment Tool
    • Self Assessment Results
    • RRI Maturity
    • RRI Maturity Results
    • Action Plan
    • Action Plan Results
  • Services
  • News
  • Contact
Account

RRI Training

I

Trusted Research Training

I

Ethical AI Systems Training

I

Stakeholder Engagement

I

Data Governance

I

Sustainable Research

  • About ORBIT
    • AREA 4P Framework
    • The Keys of RRI
    • Employment Opportunities
  • Tools
  • Contact
  • Account
    • Workshop Hub
    • Your Courses
    • Organisation RRI Maturity Archive
    • RRI Intensity Level Archive
    • Your Action Plans
    • Delete Your Account
  • Embrace Course Booking
  • Journal
  • Toggle website search
Read more about the article Xanadu: Significant Public Listing for a Full-Stack Photonic Quantum Computing Firm

Xanadu: Significant Public Listing for a Full-Stack Photonic Quantum Computing Firm

The quantum computing sector is witnessing a promising evolution, with increasing interest in both experimentation and early commercialisation. Xanadu Quantum Technologies Inc. (proposed Nasdaq ticker: XNDU) aims to leverage this…

Read more about the article FDA Grants Clearance to GE HealthCare’s Photonova Spectra Photon-Counting CT

FDA Grants Clearance to GE HealthCare’s Photonova Spectra Photon-Counting CT

GE HealthCare has received FDA clearance for its Photonova Spectra photon-counting CT technology, a development that comes shortly after the system's introduction at the Radiological Society of North America (RSNA)…

Read more about the article NKGen Biotech Presents Promising Phase 1 Troculeucel Data Indicating Cognitive Improvements in Alzheimer’s Disease at AD/PD 2026

NKGen Biotech Presents Promising Phase 1 Troculeucel Data Indicating Cognitive Improvements in Alzheimer’s Disease at AD/PD 2026

SANTA ANA, Calif., March 23, 2026 (GLOBE NEWSWIRE) — NKGen Biotech, Inc. (OTC: NKGN) has reported encouraging findings from its combined Phase 1 analyses of troculeucel data, presented at the…

Read more about the article University of Arizona and Kaohsiung Forge Semiconductor Partnership

University of Arizona and Kaohsiung Forge Semiconductor Partnership

On March 13, leaders from Taiwan and Arizona formalised a significant collaboration by signing a six-party memorandum of understanding in Tucson. This agreement aims to unite academia, government, and industry…

Read more about the article Sequential Secures $3.5 Million for Microbiome Clinical Validation

Sequential Secures $3.5 Million for Microbiome Clinical Validation

Genomic testing company Sequential, based at Chesterford Research Park, has successfully completed its inaugural equity round, raising $3.5 million. Founded in 2019, Sequential has established a robust B2B platform dedicated…

Read more about the article From a $5 Billion Deal to an $18 Billion Valuation: Tower’s Strategic Shift in AI

From a $5 Billion Deal to an $18 Billion Valuation: Tower’s Strategic Shift in AI

As conflict in the region escalated at the end of February, silicon photonics (SiPho) was initially perceived as merely another promising technology linked to artificial intelligence (AI) and data centres.…

Course Information

Help & Information

  • About ORBIT
  • Terms & Conditions
  • Privacy Policy
  • Data Breach Policy
  • Contact
  • About ORBIT
  • Terms & Conditions
  • Privacy Policy
  • Data Breach Policy
  • Contact

Contact Us

  • contact@orbit-rri.org
  • @orbitrri
  • @orbitrri

Training & Workshops

AI Empowerment

Stakeholder Engagement

Trusted Research

Data Governance

Ethical Hackathons

RRI Training

Responsible Quantum Technologies

Environmentally Sustainable Research

Design of Ethical AI Systems

  • About ORBIT
  • Terms & Conditions
  • Privacy Policy
  • Data Breach Policy
  • Contact
Copyright 2023 - ORBIT RRI a not for profit company.

By continuing to use this website, you consent to the use of cookies in accordance with our Cookie Policy.

Accept